Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
Methods for determining active ingredients in pro-drug PEG protein conjugates with releasable PEG reagents (in vitro de-pegylation)
No-Receipt date
2013-03425 - 05/11/2013
No-Filing date
20130402320 - 05/11/2013
No-Granting date
3082059 - 14/11/2013
No-EPO application date
11009919.9 - 20/10/2009
No-EPO granting date
2431741 - 21/08/2013
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
11/2013 - 02/01/2014
Expiration date
21/10/2029
Kind of title
Validation of European Patent
Legal status
VALID
Priorities
US10725708 P21/10/2008/US
US24263409 P15/09/2009/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
G01N 33/542
G01N 33/58
G01N 33/68
G01N 33/86
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
500734
NEKTAR THERAPEUTICS
455 MISSION BAY BOULEVARD SOUTH, SUITE 100
SAN FRANCISCO, CA 94158
UNITED STATES OF AMERICA (USA)
1385059
TAKEDA PHARMACEUTICAL COMPANY LIMITED
1-1, DOSHOMACHI 4-CHOME, CHUO-KU,
OSAKA-SHI, OSAKA 541-0045, JAPAN
JAPAN
Inventors
Code
Firstname
Surname
1198880
VARADI, KATALIN
1198881
SCHRENK, GERALD
1198882
ROTTENSTEINER, HANSPETER
1198883
TURECEK, PETER
1198884
WEBER, ALFRED
1198885
ANDERLE, HEINZ
1198886
CULBERTSON, SEAN M.
1198887
FANG, ZHIHAO
1198888
ZAPPE, HAROLD
1198889
ZHANG, PING
1198890
BOSSARD, MARY J.
Representatives
Code
Firstname
Surname
Address
Town
Zip
1349
ELENI
PAPAKONSTANTINOU
KOUMPARI 2
ATHINA (ATTIKIS)
10674
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
848
EFANGELIA
GIAZITZOGLOU - THOMAIDOU
KOUMPARI 2
ATHINA (ATTIKIS)
10674
GREECE
Owners History
Date
Description
Comments
Data before modification
Data after modification
01/03/2018
Μεταβίβαση (7e802)
Α.Π.317/17-1-18,ΔΝΥ329/18,ΚΩΔ.ΠΛΗΡ.3458
500733 Baxter Healthcare SA Thurgauerstrasse 130 ΕΛΒΕΤΙΑ 8152 Glattpark (Opfikon)
01/03/2018
Μεταβίβαση (7e802)
Α.Π.317/17-1-18,ΔΝΥ329/18,ΚΩΔ.ΠΛΗΡ.3458
500734 Nektar Therapeutics 455 Mission Bay Boulevard South, Suite 100 ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ San Francisco, CA 94158
500734 Nektar Therapeutics 455 Mission Bay Boulevard South, Suite 100 ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ San Francisco, CA 94158
01/03/2018
Μεταβίβαση (7e802)
Α.Π.317/17-1-18,ΔΝΥ329/18,ΚΩΔ.ΠΛΗΡ.3458
795655 Baxalta GmbH Thurgauerstrasse 130 ΕΛΒΕΤΙΑ 8152 Glattpark, Opfikon
29/11/2021
Μεταβίβαση (7e802)
Α.Π.14224, ΑΡ.ΥΠ.4421019/21, ΔΝΥ.1851, ΚΩΔ.ΠΛΗΡ.3458
795655 Baxalta GmbH Thurgauerstrasse 130 ΕΛΒΕΤΙΑ 8152 Glattpark, Opfikon
29/11/2021
Μεταβίβαση (7e802)
Α.Π.14224, ΑΡ.ΥΠ.4421019/21, ΔΝΥ.1851, ΚΩΔ.ΠΛΗΡ.3458
795656 Baxalta Incorporated 1200 Lakeside Drive ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ Bannockburn, IL 60015
500734 Nektar Therapeutics 455 Mission Bay Boulevard South, Suite 100 ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ San Francisco, CA 94158
29/11/2021
Μεταβίβαση (7e802)
Α.Π.14224, ΑΡ.ΥΠ.4421019/21, ΔΝΥ.1851, ΚΩΔ.ΠΛΗΡ.3458
Title Instruments
Date
Operation
Descreption
8/28/2023 12:00:00 AM
Διάφορες Μεταβολές (70004)
ΑΡ.ΠΡΩΤ. 4430/10-02-2023 (ΛΙΣΤΑ) (ΑΡ.ΥΠΟΘ. 4654017/10-02-2023) ΔΝΥ. 440 ΚΩΔ.ΠΛΗΡ. 3464 ΑΡΣΗ & ΑΝΤΙΚΑΤΑΣΤΑΣΗ ΑΝΤΙΚΛΗΤΟΥ
Payments history
16 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).